EATRIS-CONNECT
Aim
• Adapt EATRIS’ digital capacities for clinical decision-making
• Evolve the EATRIS business model in close alignment with national Research Infrastructure strategies
• Cultivate complementarities and synergies in the digital domain across the Research Infrastructure landscape
• Enable a more connected and efficient PerMed ecosystem
Description
EATRIS-CONNECT is an EU-funded initiative that leverages digital transformation to accelerate translational medicine. Led by EATRIS and backed by a Horizon Europe budget of €3.9 million, this three-year project (May 2024¬April 2027) brings together 21 organisations from across Europe. The project focuses on cross-border alignment and will equip the infrastructure with new digital capacities with a particular focus on AI-enabled technologies, advancing digital readiness while promoting environmentally sustainable digital transformation in EATRIS ERIC and its 14 national nodes. This project aligns with commitment to the Digital Europe Programme’s goal of making Europe both greener and more digital.
Impact and long-term vision
EATRIS-CONNECT represents a pathway for EATRIS to evolve into a fully digitalready infrastructure capable of addressing bottlenecks in translational medicine and expanding its role in personalised medicine. Through strengthened digital competencies, interdisciplinary collaboration, and environmentally responsible practices, the project will help secure EATRIS’ long-term sustainability. By consolidating EATRIS’s digital infrastructure landscape, EATRIS-CONNECT paves the way for accelerated innovation and enhanced collaboration across Europe, positioning EATRIS as a central player in the personalised medicine ecosystem.
Lead partner
EATRIS ERIC (Netherlands)
Project partners
Servicio Madrileño de Salud (Spain), Palacký University Olomouc (Czechia), Itä-Suomen yliopisto (Finland), Zagreb Medical School (Croatia), Istituto Superiore di Sanita (Italy), INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. (Portugal), Luxembourg Institute of Health (Luxembourg), University of Ljubljana (Slovenia), Sofia University St. Kliment Ohridski (Bulgaria), Universitetet I Oslo (Norway), Uppsala University (Sweden), Commissariat à l’énergie atomique et aux énergies alternatives (France), University of Helsinki (Finland), Stichting Health-ri (Netherlands), IRCCS Istituto di ricerche farmacologiche Mario Negri (Italy), Aibili Associacao Para (Portugal), The Provost, Fellows, Foundation Scholars, and other members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin (Ireland), Fundacio Hospital Universitari Vall d'Hebron – Institut de Recerca (Spain)
